{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Parkinson's disease",
      "high-intensity exercise",
      "mitochondria",
      "muscle hypertrophy",
      "resistance training"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24408997",
  "DateCompleted": {
    "Year": "2014",
    "Month": "10",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2014",
        "Month": "01",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1152/japplphysiol.01277.2013"
    ],
    "Journal": {
      "ISSN": "1522-1601",
      "JournalIssue": {
        "Volume": "116",
        "Issue": "5",
        "PubDate": {
          "Year": "2014",
          "Month": "Mar",
          "Day": "01"
        }
      },
      "Title": "Journal of applied physiology (Bethesda, Md. : 1985)",
      "ISOAbbreviation": "J Appl Physiol (1985)"
    },
    "ArticleTitle": "Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.",
    "Pagination": {
      "StartPage": "582",
      "EndPage": "592",
      "MedlinePgn": "582-92"
    },
    "Abstract": {
      "AbstractText": [
        "We conducted, in persons with Parkinson's disease (PD), a thorough assessment of neuromotor function and performance in conjunction with phenotypic analyses of skeletal muscle tissue, and further tested the adaptability of PD muscle to high-intensity exercise training. Fifteen participants with PD (Hoehn and Yahr stage 2-3) completed 16 wk of high-intensity exercise training designed to simultaneously challenge strength, power, endurance, balance, and mobility function. Skeletal muscle adaptations (P < 0.05) to exercise training in PD included myofiber hypertrophy (type I: +14%, type II: +36%), shift to less fatigable myofiber type profile, and increased mitochondrial complex activity in both subsarcolemmal and intermyofibrillar fractions (I: +45-56%, IV: +39-54%). These adaptations were accompanied by a host of functional and clinical improvements (P < 0.05): total body strength (+30-56%); leg power (+42%); single leg balance (+34%); sit-to-stand motor unit activation requirement (-30%); 6-min walk (+43 m), Parkinson's Disease Quality of Life Scale (PDQ-39, -7.8pts); Unified Parkinson's Disease Rating Scale (UPDRS) total (-5.7 pts) and motor (-2.7 pts); and fatigue severity (-17%). Additionally, PD subjects in the pretraining state were compared with a group of matched, non-PD controls (CON; did not exercise). A combined assessment of muscle tissue phenotype and neuromuscular function revealed a higher distribution and larger cross-sectional area of type I myofibers and greater type II myofiber size heterogeneity in PD vs. CON (P < 0.05). In conclusion, persons with moderately advanced PD adapt to high-intensity exercise training with favorable changes in skeletal muscle at the cellular and subcellular levels that are associated with improvements in motor function, physical capacity, and fatigue perception."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "UAB Center for Exercise Medicine, University of Alabama at Birmingham, Birmingham, Alabama;"
          }
        ],
        "LastName": "Kelly",
        "ForeName": "Neil A",
        "Initials": "NA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ford",
        "ForeName": "Matthew P",
        "Initials": "MP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Standaert",
        "ForeName": "David G",
        "Initials": "DG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Watts",
        "ForeName": "Ray L",
        "Initials": "RL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bickel",
        "ForeName": "C Scott",
        "Initials": "CS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Moellering",
        "ForeName": "Douglas R",
        "Initials": "DR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tuggle",
        "ForeName": "S Craig",
        "Initials": "SC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Williams",
        "ForeName": "Jeri Y",
        "Initials": "JY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lieb",
        "ForeName": "Laura",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Windham",
        "ForeName": "Samuel T",
        "Initials": "ST"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bamman",
        "ForeName": "Marcas M",
        "Initials": "MM"
      }
    ],
    "GrantList": [
      {
        "GrantID": "T32 HD071866",
        "Acronym": "HD",
        "Agency": "NICHD NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "1T32 HD071866",
        "Acronym": "HD",
        "Agency": "NICHD NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P30DK079626",
        "Acronym": "DK",
        "Agency": "NIDDK NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Appl Physiol (1985)",
    "NlmUniqueID": "8502536",
    "ISSNLinking": "0161-7567"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiparkinson Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiparkinson Agents"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Body Composition"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Hemodynamics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Isometric Contraction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Mitochondria, Muscle"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Motor Neurons"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Muscle Fatigue"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Muscle Fibers, Skeletal"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Muscle Strength"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Muscle, Skeletal"
    },
    {
      "QualifierName": [
        "physiopathology",
        "therapy"
      ],
      "DescriptorName": "Parkinson Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Compliance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prescriptions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}